glp 1 with nad GLP-1-based therapies for diabetes, obesity and beyond Small just got more powerful:

GLP-1 receptor agonists have a very good profile in terms of reducing excess weight and inflammation, both of which have established links to cancer," Jiang Bian, PhD, MS, FACMI, associate dean for data science at Indiana University School of Medicine and chief data scientist for IU Health and Regenstrief Institute, told Healio

So instead of guessing on your own, youve got a team looking at whats actually happening in your body and building a plan to get your GLP-1-related symptoms under control

As of 2024, over 2% of Americans use GLP-1s for overweight/obesity, and around 4% use them overall (for any indication), with nearly half of users using them for weight loss

Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor